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Abstract
Myofibroma is an uncommon spindle cell neoplasm rarely found in oral cavity. Typically, this lesion is seen in 
neonates and infants with few cases reported in adults patients. In the oral cavity, myofibroma occurs within the 
submucosal or intramuscular tissue and has a predilection by the tongue, buccal mucosa and lips. Microscopically, 
a typical biphasic pattern can be observed. Misdiagnosis included benign and malignant spindle cell lesions of 
nerve tissue or smooth muscle origin, such as neurofibroma, leiomyoma and sarcomas. Thus, immunohistochemi-
cal staining is a useful tool to identify the nature of neoplastic cells and to reach an accurate diagnosis. An immu-
nohistochemical panel consisting of antibodies to vimentin, SMA, HHF-35, S-100p and desmin must be achieved. 
In most cases, positivity for vimentin, SMA and HHF-25 can be observed. Our report describes a solitary myofi-
broma of the tongue of a 23-year-old man with emphasis in clinical, histopathological and immunohistochemical 
features of this lesion. 
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Introduction
Myofibroma is a rare, benign mesenchymal tumor, most 
of which develop in infancy or before the age of 2 years. 
It was first described by Stout (1) in 1954 as congenital 
generalized fibromatosis and renamed as infantile my-
ofibromatosis by Chung et al. (2) in 1981. The last name 
reflected the typically young age at onset of this disease 
and the myofibroblastic nature of the neoplastic cells. 
However, Smith et al. (3) later introduced the term my-
ofibroma to note that such lesions were most commonly 
solitary and not exclusively pediatric. According Chung 
et al.(2), about one-third of all myofibromas occur in 
head and neck, with few cases reported in oral soft tis-
sues. This communication describes a solitary myofi-
broma of the tongue of a 23-year-old man with emphasis 
in clinical, histopathological and immunohistochemical 
features of this lesion. 
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Case Report
A 23-year-old man visited the Department of Oral Pa-
thology, Federal University of Sergipe, Brazil, for eva-
luation of a painless swelling on the tongue present for 
approximately 7 months. The patient denied any dys-
phagia, odynophagia, difficulty breathing or swallo-
wing. The medical history and review of symptoms 
were noncontributory. There was no history of similar 
lesions in the patient or members of his family. Intra-
oral examination revealed a firm, localized swelling in 
the left posterior tongue border. The overlying mucosa 
was of normal color and ulceration was not noted. 
The patient was admitted for surgical intervention and 
the lesion was excised under general anesthesia. Ma-
croscopic examination revealed off-white ovoid firm 
mass with a homogenous texture measured 1.5 cm in 
its greatest dimension (Fig. 1). Microscopic examina-
tion of 5 sections stained with hematoxylin and eosin 
(HE) revealed a well-circumscribed tumor composed of 
spindle-shaped cells arranged in a biphasic pattern. The 
periphery of the tumor contained more mature spindle-
shaped cells in an interlacing pattern. These spindle-
shaped cells were large and elongated with eosinophilic 
cytoplasm and oval tapering-end nuclei. Nuclear atypia 
and mitotic figures were not seen. The central portion 
of the lesion contained more immature-appearing cells 
with hemangioperycitoma-like pattern (Fig. 2).
Fig 1. A, Clinical presentation of myofibroma. A submucosal nodule 
in the left posterior tongue border. B, gross examination of myofi-
broma after excision.
Fig 2. Histologic features of myofibroma (hematoxylin-eosin stain). A, the tumor cells exhibiting a biphasic pattern (original magnification 
x50). B, higher power view showing an area with hemangiopericytoma-like pattern of the blood vessel (original magnification x500). C, pho-
tomicrography showing the large elongated cells with tapering ends (original magnification x100). D, interlacing fascicular arrangement of 
myofibroblast closely resembling smooth muscle tumor (original magnification x100).
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Immunohistochemical staining showed positivity for 
vimentin and smooth muscle actin (SMA), but was ne-
gative for desmin and S-100p (Fig. 3). On the basis of 
histopathologic and immunohistochemical features, fi-
nal diagnosis of myofibroma was rendered. The patient 
has shown no signs of recurrence 2 years after surgery.
Discussion
Solitary myofibroma is a rare benign spindle cell neo-
plasm that may arise in the skin, subcutis, soft tissue, 
bone, and, exceptionally, in viscera. In the head and 
neck, the most frequent site is bone, followed by buccal 
mucosa and tongue (4). According Jordan and Regezi 
(5), the prevalence of solitary myofibroma in the oral 
cavity is very low. The authors reviewed 307 nono-
dontogenic spindle cell neoplasms accessioned over a 
20-year period from an oral pathology service and ob-
served that only 8 cases were diagnosed as myofibroma. 
In a recent review of English language literature, Vered 
et al. (6) found only 41 cases of oral soft tissue myofi-
broma.
Typically, this lesion is seen in neonates and infants 
with few cases reported in adults patients. In the oral 
cavity, the tumor frequently occurs within the submu-
cosal or intramuscular tissue and has a predilection by 
the tongue, buccal mucosa and lips. Clinically, these 
are usually slow-growing painless soft tissue swellings 
with an intact mucosa unless secondarily ulcerated (7). 
They typically range in size from 0.5 to 5.0 cm (8).
Surgical excision is the treatment of choice for myofi-
broma. The prognosis of this rare tumor is excellent af-
ter conservative surgical curettage or resection (9). Ac-
cording Daimaru et al. (10), the recurrence rate is only 
7% after excision. In agreement with previous reports, 
there was no evidence of recurrence after over the two 
years of follow-up. 
Gross examination revealed a well-delimited mass that 
varied from white to pinktan to gray with a firm or grit-
ty consistency (8). Three cell types can be recognized 
on the electron microscopic examination: myofibro-
blast-like cells, fibroblastic-like cells and intermediate 
cells. A majority of the tumor cells are composed by 
intermediate cells type and myofibroblastic-like cells 
had cytoplasmatic filaments with dense bodies, basal 
lamina, pinocytotic vesicles and nuclear invaginations 
(9). However, electron microscopic evaluation of tumor 
specimens is not routinely used in most pathology ser-
vices. In the current case, definitive diagnosis was made 
on the basis of the histopathological and immunohisto-
chemical findings. 
Microscopically, a typical biphasic pattern can be ob-
served. Peripheral zone of myofibroma is composed of 
spindle-shaped cells with long oval nuclei and abundant 
eosinophilic cytoplasm that resembled smooth muscle. 
Fig 3. Immunohistochemical staining reveals the strong expression of smooth muscle actin (original magnification A, 
x200 and B, x400).
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Central portion of this tumor comprise a population of 
more primitive spindle cells associated with a heman-
giopericytoma-like vascular pattern (7,9). In rare cases, 
reversal of typical zonation as well as necrosis and cal-
cification can be observed (11). In current case, there 
was no necrosis and calcification, but multiple slit-like 
vascular spaces resembling hemangiopericytoma. 
Immunohistochemical staining is a useful tool to identi-
fy the nature of neoplastic cells and to reach an accurate 
diagnosis. An immunohistochemical panel consisting 
of antibodies to vimentin, S-100p, desmin, HHF-35 and 
SMA must be achieved (4,5,7,9, 11-13) (Table 1). Vimen-
tin is the most widely expressed intermediate filament 
protein thought to be involved in structural processes. 
This protein is a general marker of cells originating in 
the mesenchyme and is frequently included in the so-
called primary panel together with others antibodies 
such as cytokeratins, neurofilaments, S-100 and des-
min. Intense staining reaction for vimentin without 
coexpression of other intermediate filament proteins is 
strongly suggestive of a mesenchymal tumor such as 
sarcomas and lymphomas (14).
S-100p is an acidic nuclear protein specific for the ner-
vous system that regulates intracellular processes such 
as cell growth and motility, cell cycle regulation, trans-
cription and differentiation. This protein is often used 
in the differential diagnosis of tumors of neural origin 
(5).
Desmin is as intermediate filament protein of both stri-
ated and smooth muscles useful in identification of tu-
mors of myogenic origin, such as myofibrosarcomas, 
leiomyosarcomas and rhabdomyosarcomas (8). HHF-
35, a muscle-actin specific monoclonal antibody, has 
also been used as a marker for soft tissue tumors with 
muscle differentiation, for which it displayed a higher 
degree of sensitivity than desmin antibodies. HHF-35 
reacts with skeletal muscle cells, cardiac muscle cells, 
smooth muscle cells, pericytes and myoepithelial cells, 
but is nonreactive with endothelial, neural or connective 
tissue cells (15). Some authors have used this marker 
recently in diagnosis of myofibroma (11). 
Smooth muscle actin expression is the most used mark-
er for myofibroblast identification. Foss et al. (8) exam-
ined immunohistochemically 39 cases of oral myofi-
broma and verified 100% positivity for this protein.  In 
our case, positive staining for smooth muscle actin was 
obtained, confirming the myofibroblastic origin of the 
tumor. 
Misdiagnosis included benign and malignant spindle 
cell lesions of nerve tissue or smooth muscle origin, 
such as neurofibroma, leiomyoma and sarcomas. Thus, 
knowledge about myofibroma is important to establish 
the correct diagnosis and avoid morbidity of unneces-
sary aggressive therapy (11). 
In summary, because of the scarcity of smooth muscle in 
the oral cavity, the myofibroma is a relatively uncommon 
lesion in that location. The tumor can be present as slow-
growing, asymptomatic, firm submucosal swelling that is 
rarely ulcerated.  Immunohistochemistry is a valuable, 
precise and reliable method for establishing a definitive 
diagnosis of this lesion. 
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